CCL21-loaded 3D hydrogels for T cell expansion and differentiation

Area of Science:

• Biotechnology and Biomedical Engineering
• Immunotherapy and Cancer Research

Background:

• Adoptive cell therapy shows promise in cancer treatment but faces manufacturing limitations.
• Current methods struggle with efficient, large-scale, and cost-effective production of therapeutic T cells.

Purpose of the Study:

• To engineer a novel 3D hydrogel system that mimics lymph node microenvironments.
• To improve the expansion of primary human CD4+ T cells for adoptive cell therapy.

Main Methods:

• Fabrication of 3D poly(ethylene) glycol (PEG) hydrogels with covalently linked low molecular weight heparin.
• Incorporation of heparin as an anchor for the cytokine CCL21 to promote T cell functions.
• Comparison of T cell proliferation in the hydrogel system versus traditional artificial antigen-presenting cells.

Main Results:

• The engineered 3D hydrogel provided structural and mechanical support for T cell expansion.
• Heparin-anchored CCL21 enhanced T cell migration and proliferation.
• Significantly increased proliferation of primary human CD4+ T cells was observed compared to existing systems.

Conclusions:

• The lymph node-mimicking 3D hydrogel is a promising new tool for adoptive cell therapy.
• This system facilitates the production of large numbers of therapeutic T cells required for cancer treatment.
• The engineered hydrogel offers a viable solution to current manufacturing challenges in T cell therapy.